Logo image of A7A.DE

HELIAD AG (A7A.DE) Stock Fundamental Analysis

FRA:A7A - Deutsche Boerse Ag - DE0001218063 - Common Stock - Currency: EUR

14.3  -0.3 (-2.05%)

Fundamental Rating

3

Taking everything into account, A7A scores 3 out of 10 in our fundamental rating. A7A was compared to 106 industry peers in the Capital Markets industry. A7A has a medium profitability rating, but doesn't score so well on its financial health evaluation. A7A has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year A7A was profitable.
The reported net income has been mixed in the past 5 years: A7A reported negative net income in multiple years.
A7A had negative operating cash flow in 4 of the past 5 years.
A7A.DE Yearly Net Income VS EBIT VS OCF VS FCFA7A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of A7A (2.82%) is better than 65.09% of its industry peers.
A7A has a Return On Equity (3.59%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 1.67%, A7A is in line with its industry, outperforming 59.43% of the companies in the same industry.
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROIC 1.67%
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
A7A.DE Yearly ROA, ROE, ROICA7A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

A7A's Profit Margin of 519.85% is amongst the best of the industry. A7A outperforms 97.17% of its industry peers.
In the last couple of years the Profit Margin of A7A has declined.
A7A has a better Operating Margin (431.95%) than 100.00% of its industry peers.
A7A's Operating Margin has improved in the last couple of years.
A7A has a Gross Margin of 93.38%. This is amongst the best in the industry. A7A outperforms 89.62% of its industry peers.
A7A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
A7A.DE Yearly Profit, Operating, Gross MarginsA7A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, A7A has about the same amount of shares outstanding.
The number of shares outstanding for A7A has been increased compared to 5 years ago.
A7A has a worse debt/assets ratio than last year.
A7A.DE Yearly Shares OutstandingA7A.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
A7A.DE Yearly Total Debt VS Total AssetsA7A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 4.46 indicates that A7A is not in any danger for bankruptcy at the moment.
A7A has a Altman-Z score of 4.46. This is amongst the best in the industry. A7A outperforms 86.79% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that A7A is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.24, A7A is in the better half of the industry, outperforming 70.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.46
ROIC/WACCN/A
WACCN/A
A7A.DE Yearly LT Debt VS Equity VS FCFA7A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A Current Ratio of 0.57 indicates that A7A may have some problems paying its short term obligations.
The Current ratio of A7A (0.57) is comparable to the rest of the industry.
A Quick Ratio of 0.57 indicates that A7A may have some problems paying its short term obligations.
A7A has a Quick ratio (0.57) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
A7A.DE Yearly Current Assets VS Current LiabilitesA7A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.16% over the past year.
The earnings per share for A7A have been decreasing by -46.21% on average. This is quite bad
The Revenue for A7A has decreased by -40.16% in the past year. This is quite bad
The Revenue for A7A have been decreasing by -33.67% on average. This is quite bad
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
A7A.DE Yearly Revenue VS EstimatesA7A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
A7A.DE Yearly EPS VS EstimatesA7A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2023 2024 2025 2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A7A is valuated quite expensively with a Price/Earnings ratio of 43.33.
A7A's Price/Earnings is on the same level as the industry average.
A7A's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.21.
The Price/Forward Earnings ratio is 70.79, which means the current valuation is very expensive for A7A.
A7A's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.44. A7A is valued rather expensively when compared to this.
Industry RankSector Rank
PE 43.33
Fwd PE 70.79
A7A.DE Price Earnings VS Forward Price EarningsA7A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
A7A.DE Per share dataA7A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

A7A does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HELIAD AG

FRA:A7A (5/9/2025, 7:00:00 PM)

14.3

-0.3 (-2.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-30 2025-04-30
Earnings (Next)09-29 2025-09-29
Inst Owners0.89%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap120.26M
Analysts80
Price Target15.81 (10.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 43.33
Fwd PE 70.79
P/S 227.34
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)0.33
EY2.31%
EPS(NY)0.2
Fwd EY1.41%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS9.11
TBVpS9.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROCE 2.93%
ROIC 1.67%
ROICexc 1.79%
ROICexgc 1.79%
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
FCFM N/A
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-8.62%
ROICexcg growth 5Y12.14%
ROICexc growth 3Y-8.62%
ROICexc growth 5Y12.14%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 4.46
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y454.81%
EBIT growth 3Y11.06%
EBIT growth 5Y2.9%
EBIT Next Year-100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A